Literature DB >> 33155569

Rapid progression of scoliosis curve in a mature patient with undiagnosed pituitary macroadenoma: A rare case report.

Weng Hong Chung1, Chee Kidd Chiu1, Chris Yin Wei Chan1, Mun Keong Kwan1.   

Abstract

Growth hormone secreting pituitary tumor or gigantism has not been previously reported to be associated with rapid progression of scoliosis in the literature. However, there are some reports indicating scoliosis can be worsened by growth hormone therapy in children and adolescents. A 19-year-old boy was referred to our institution for the treatment of a right thoracolumbar scoliosis. The Cobb angle had worsened from 29° to 83° over two years' duration. He attained puberty at the age of 13. He had a previous history of slipped upper femoral epiphysis (SUFE), which was operated in 2015, with no clinical features of gigantism. Preoperative assessment was performed. He was diagnosed with growth hormone secreting pituitary macroadenoma by magnetic resonance imaging with a high serum level of insulin-like growth factor-I (IGF-I). Computed tomography (CT) of the pancreas showed a pancreatic endocrine tumor. The patient was later diagnosed with multiple endocrine neoplasia type 1 (MEN 1). He underwent endoscopic endonasal excision of the pituitary mass and distal pancreatectomy. This case indicates that growth hormone secreting pituitary macroadenoma could result in rapid progression of scoliosis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33155569      PMCID: PMC7646617          DOI: 10.5152/j.aott.2020.19144

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  11 in total

1.  Progression of a structural scoliosis during treatment with growth hormone. A case report.

Authors:  J F Dymling; S Willner
Journal:  Acta Orthop Scand       Date:  1978-06

2.  Significant increases of pituitary tumors and resections from 1993 to 2011.

Authors:  Jennifer A Villwock; Mark Villwock; Eric Deshaies; Parul Goyal
Journal:  Int Forum Allergy Rhinol       Date:  2014-08-22       Impact factor: 3.858

3.  Scoliosis in patients treated with growth hormone.

Authors:  E D Wang; D S Drummond; J P Dormans; T Moshang; R S Davidson; D Gruccio
Journal:  J Pediatr Orthop       Date:  1997 Nov-Dec       Impact factor: 2.324

4.  Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).

Authors:  Maria E Craig; Christopher T Cowell; Pontus Larsson; William B Zipf; Edward O Reiter; Kerstin Albertsson Wikland; Michael B Ranke; David A Price
Journal:  Clin Endocrinol (Oxf)       Date:  2006-08       Impact factor: 3.478

5.  Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

6.  Long-term safety of recombinant human growth hormone in children.

Authors:  J Bell; K L Parker; R D Swinford; A R Hoffman; T Maneatis; B Lippe
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

Review 7.  Biochemical markers of acromegaly: GH vs. IGF-I.

Authors:  Ariel L Barkan
Journal:  Growth Horm IGF Res       Date:  2004-06       Impact factor: 2.372

8.  Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Authors:  Alberto Fernandez; Niki Karavitaki; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-24       Impact factor: 3.478

9.  Curve Progression in Adolescent Idiopathic Scoliosis Does Not Match Skeletal Growth.

Authors:  Jason Pui Yin Cheung; Prudence Wing Hang Cheung; Dino Samartzis; Keith Dip-Kei Luk
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

Review 10.  Diagnosis and Treatment of Pituitary Adenomas: A Review.

Authors:  Mark E Molitch
Journal:  JAMA       Date:  2017-02-07       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.